Literature DB >> 1963464

Tissue distribution of cellular retinol-binding protein and cellular retinoic acid-binding protein: use of monospecific antibodies for immunohistochemistry and cRNA for in situ localization of mRNA.

C Busch, P Sakena, K Funa, H Nordlinder, U Eriksson.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1963464     DOI： 10.1016/0076-6879(90)89303-y

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo.

Authors:  P Neuville; A Geinoz; G Benzonana; M Redard; F Gabbiani; P Ropraz; G Gabbiani
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Expression of cellular retinol- and retinoic acid-binding proteins in normal and pathologic human parathyroid glands.

Authors:  H Melhus; Q Li; H Nordlinder; L O Farnebo; L Grimelius
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Expression of CRABP-I and -II in human epidermal cells. Alteration of relative protein amounts is linked to the state of differentiation.

Authors:  G Siegenthaler; I Tomatis; D Chatellard-Gruaz; S Jaconi; U Eriksson; J H Saurat
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

4.  Vitamin A metabolism is impaired in human ovarian cancer.

Authors:  Stephen J Williams; Dusica Cvetkovic; Thomas C Hamilton
Journal:  Gynecol Oncol       Date:  2008-12-25       Impact factor: 5.482

5.  Members of the fatty acid binding protein family are differentiation factors for the mammary gland.

Authors:  Y Yang; E Spitzer; N Kenney; W Zschiesche; M Li; A Kromminga; T Müller; F Spener; A Lezius; J H Veerkamp
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

6.  Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.

Authors:  Alice Arapshian; Silvina Bertran; Yuvarani S Kuppumbatti; Shigeo Nakajo; Rafael Mira-y-Lopez
Journal:  Mol Cancer       Date:  2004-04-27       Impact factor: 27.401
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.